Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Inflammation and infection models, from allergic diseases and inflammatory conditions to sepsis and respiratory infections, provide therapeutic insight at an early stage.
We have extensive experience with a wide range of pathogens and disease-inducing stimuli, and can support you from the screening process to finally putting your compounds to the test in a disease model.
Our fully equipped labs, including (in vivo) BSL2 facilities, allow for a wide variety of experimental setups, and our compassionate team will work together with you to tailor the study to your needs. For example, wound or respiratory infection models can be used to evaluate antimicrobial therapies or immune modulators, while inflammation models, mimicking allergy or inflammatory bowel disease, allow for evaluation of anti-inflammatory drugs.
By using translational models that recapitulate the complex processes of inflammation and infection, we can provide essential insights into the therapeutic potential of your compound at an early stage in the development process.
